Acadian Asset Management LLC Actinium Pharmaceuticals, Inc. Transaction History
Acadian Asset Management LLC
- $35.4 Billion
- Q1 2025
A detailed history of Acadian Asset Management LLC transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 504,038 shares of ATNM stock, worth $882,066. This represents 0.0% of its overall portfolio holdings.
Number of Shares
504,038
Previous 499,260
0.96%
Holding current value
$882,066
Previous $628,000
28.98%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ATNM
# of Institutions
72Shares Held
8.18MCall Options Held
51.9KPut Options Held
6.2K-
Black Rock Inc. New York, NY1.88MShares$3.28 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.57MShares$2.75 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA712KShares$1.25 Million0.0% of portfolio
-
State Street Corp Boston, MA645KShares$1.13 Million0.0% of portfolio
-
Ubs Group Ag396KShares$693,2380.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $44.1M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...